| 000 | 01831 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250515015006.0 | ||
| 264 | 0 | _c20060710 | |
| 008 | 200607s 0 0 eng d | ||
| 022 | _a1349-7235 | ||
| 024 | 7 |
_a10.2169/internalmedicine.45.1427 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTakagi, Junko | |
| 245 | 0 | 0 |
_aMultiple endocrine neoplasia type I and Cushing's syndrome due to an aggressive ACTH producing thymic carcinoid. _h[electronic resource] |
| 260 |
_bInternal medicine (Tokyo, Japan) _c2006 |
||
| 300 |
_a81-6 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 |
_aACTH Syndrome, Ectopic _xblood |
| 650 | 0 | 4 |
_aAdrenocorticotropic Hormone _xblood |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Hormonal _xtherapeutic use |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
| 650 | 0 | 4 |
_aCarcinoid Tumor _xblood |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aCushing Syndrome _xblood |
| 650 | 0 | 4 | _aFatal Outcome |
| 650 | 0 | 4 | _aGerm-Line Mutation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMultiple Endocrine Neoplasia Type 1 _xblood |
| 650 | 0 | 4 |
_aOctreotide _xtherapeutic use |
| 650 | 0 | 4 | _aRadiotherapy, Adjuvant |
| 650 | 0 | 4 | _aThymectomy |
| 650 | 0 | 4 |
_aThymus Neoplasms _xblood |
| 700 | 1 | _aOtake, Kazuo | |
| 700 | 1 | _aMorishita, Munehiko | |
| 700 | 1 | _aKato, Harumichi | |
| 700 | 1 | _aNakao, Naoki | |
| 700 | 1 | _aYoshikawa, Kazuhiro | |
| 700 | 1 | _aIkeda, Hiroshi | |
| 700 | 1 | _aHirooka, Yoshifumi | |
| 700 | 1 | _aHattori, Yoshinobu | |
| 700 | 1 | _aLarsson, Catharina | |
| 700 | 1 | _aNogimori, Tsuyoshi | |
| 773 | 0 |
_tInternal medicine (Tokyo, Japan) _gvol. 45 _gno. 2 _gp. 81-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2169/internalmedicine.45.1427 _zAvailable from publisher's website |
| 999 |
_c16096309 _d16096309 |
||